These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 39023524
1. Antifungal susceptibility pattern of Candida auris strains: Analysis of clinical strains in a tertiary-care educational university hospital. Khairy A, Hejres S, Elbahr U, Dayyab F, Delos Reyes CS, Pastrana JA, Vineeth C, Prem Sudha S, Keskin O, Singh Rana S, Fadel E, Erdem H, Sipahi OR. New Microbiol; 2024 Jul; 47(2):152-156. PubMed ID: 39023524 [Abstract] [Full Text] [Related]
2. Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023. Siopi M, Georgiou PC, Paranos P, Beredaki MI, Tarpatzi A, Kalogeropoulou E, Damianidou S, Vasilakopoulou A, Karakosta P, Pournaras S, Meletiadis J. Euro Surveill; 2024 Jul; 29(29):. PubMed ID: 39027938 [Abstract] [Full Text] [Related]
3. Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran. Badiee P, Boekhout T, Haddadi P, Mohammadi R, Ghadimi-Moghadam A, Soltani J, Zarei Mahmoudabadi A, Ayatollahi Mousavi SA, Najafzadeh MJ, Diba K, Salimi-Khorashad AR, Amin Shahidi M, Ghasemi F, Jafarian H. Microbiol Spectr; 2022 Dec 21; 10(6):e0245322. PubMed ID: 36445122 [Abstract] [Full Text] [Related]
4. Candida auris - Comparison of sensititre YeastOne and Vitek 2 AST systems for antifungal susceptibility testing - A single centre experience. Patwardhan SA, Prayag PS, Soman RN, Purandare BD, Ramya S, Dawra R, Joshi R, Prayag AP. Indian J Med Microbiol; 2024 Dec 21; 50():100618. PubMed ID: 38795936 [Abstract] [Full Text] [Related]
5. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern. Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P, Meis JF, Boekhout T. Infection; 2014 Apr 21; 42(2):393-404. PubMed ID: 24352810 [Abstract] [Full Text] [Related]
6. Necessity to identify candida species accurately with minimum inhibitory concentration determination in each case of bloodstream infections. Pandey N, Gupta MK, Paul P, Tilak R. J Infect Public Health; 2020 May 21; 13(5):753-758. PubMed ID: 31899133 [Abstract] [Full Text] [Related]
7. Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization. Castanheira M, Deshpande LM, Rhomberg PR, Carvalhaes CG. Antimicrob Agents Chemother; 2024 Oct 08; 68(10):e0057024. PubMed ID: 39264189 [Abstract] [Full Text] [Related]
8. Antifungal susceptibility profile of invasive Candida glabrata isolates (2009-2020) from a tertiary care hospital laboratory in Pakistan. Memon S, Farooqi J, Zafar U, Naqvi SF, Zafar A, Jabeen K. J Med Microbiol; 2021 Dec 08; 70(12):. PubMed ID: 34878377 [Abstract] [Full Text] [Related]
14. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs. Ahmad S, Khan Z, Al-Sweih N, Alfouzan W, Joseph L. Mycoses; 2020 Jan 08; 63(1):104-112. PubMed ID: 31618799 [Abstract] [Full Text] [Related]